Corinne Johnson
Stock Analyst at Goldman Sachs
(3.33)
# 992
Out of 5,123 analysts
17
Total ratings
57.14%
Success rate
20.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Maintains: Neutral | $37 → $39 | $27.76 | +40.49% | 1 | Jan 15, 2026 | |
| IMVT Immunovant | Maintains: Neutral | $18 → $28 | $24.06 | +16.38% | 2 | Dec 15, 2025 | |
| MBX MBX Biosciences | Initiates: Sell | $18 | $36.05 | -50.07% | 1 | Dec 4, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $10 → $20 | $12.99 | +53.96% | 2 | Sep 16, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $20 → $24 | $20.15 | +19.11% | 2 | Sep 5, 2025 | |
| RNA Avidity Biosciences | Reinstates: Buy | $55 | $72.82 | -24.47% | 2 | Jul 10, 2025 | |
| AVBP ArriVent BioPharma | Reinstates: Buy | $33 | $21.35 | +54.57% | 3 | Jul 10, 2025 | |
| NBIX Neurocrine Biosciences | Initiates: Buy | $182 | $137.89 | +31.99% | 1 | Jul 10, 2025 | |
| CGON CG Oncology | Upgrades: Buy | $43 → $50 | $49.21 | +1.61% | 3 | May 14, 2024 |
TG Therapeutics
Jan 15, 2026
Maintains: Neutral
Price Target: $37 → $39
Current: $27.76
Upside: +40.49%
Immunovant
Dec 15, 2025
Maintains: Neutral
Price Target: $18 → $28
Current: $24.06
Upside: +16.38%
MBX Biosciences
Dec 4, 2025
Initiates: Sell
Price Target: $18
Current: $36.05
Upside: -50.07%
Amylyx Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $12.99
Upside: +53.96%
Syndax Pharmaceuticals
Sep 5, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $20.15
Upside: +19.11%
Avidity Biosciences
Jul 10, 2025
Reinstates: Buy
Price Target: $55
Current: $72.82
Upside: -24.47%
ArriVent BioPharma
Jul 10, 2025
Reinstates: Buy
Price Target: $33
Current: $21.35
Upside: +54.57%
Neurocrine Biosciences
Jul 10, 2025
Initiates: Buy
Price Target: $182
Current: $137.89
Upside: +31.99%
CG Oncology
May 14, 2024
Upgrades: Buy
Price Target: $43 → $50
Current: $49.21
Upside: +1.61%